Evidence map›Paper›PMID 34564142›Full record

ReviewMarine drugs2021

Exploiting of Secondary Raw Materials from Fish Processing Industry as a Source of Bioactive Peptide-Rich Protein Hydrolysates.

Girija Gajanan Phadke, Nikheel Bhojraj Rathod, Fatih Ozogul, Krishnamoorthy Elavarasan, Muthusamy Karthikeyan, Kyung-Hoon Shin, Se-Kwon Kim

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Tuna trimmingsCurrent research in food science · 2023
    Article
  13. Antidiabetic effects of protein hydrolysates fromCurrent research in food science · 2023
    Article
  14. Sea Bass Essence fromMetabolites · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Girija Gajanan PhadkeNetwork for Fish Quality Management & Sustainable Fishing (NETFISH), The Marine Products Export Development Authority (MPEDA), Navi Mumbai 410206, Maharashtra, India.ORCID 0000-0002-0316-4268
Nikheel Bhojraj RathodDepartment of Post Harvest Management of Meat, Poultry and Fish, Post Graduate Institute of Post-Harvest Management, Dr. Balasaheb Sawant Konkan Krishi Vidyapeeth, Roha 402109, Maharashtra, India.ORCID 0000-0003-1561-5924
Fatih OzogulDepartment of Seafood Processing Technology, Faculty of Fisheries, Cukurova University, Adana 01330, Turkey.ORCID 0000-0002-0655-0105
Krishnamoorthy ElavarasanFish Processing Division, ICAR-Central Institute of Fisheries Technology, Willingdon Island, Kochi 682029, Kerala, India.ORCID 0000-0002-3060-0766
Muthusamy KarthikeyanThe Marine Products Export Development Authority (MPEDA), Kochi 682036, Kerala, India.
Kyung-Hoon ShinDepartment of Marine Science & Convergence Engineering, Hanyang University, ERICA Campus, Ansan 11558, Gyeonggi-do, Korea.ORCID 0000-0002-3169-4274
Se-Kwon KimDepartment of Marine Science & Convergence Engineering, Hanyang University, ERICA Campus, Ansan 11558, Gyeonggi-do, Korea.
Hanyang University · KRCentral Institute of Fisheries Technology · INCukurova University · TRDelhi Development Authority · INDr. Balasaheb Sawant Konkan Krishi Vidyapeeth · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing peptide-based drugs are very promising to address many of the lifestyle mediated diseases which are prevalent in a major portion of the global population. As an alternative to synthetic peptide-based drugs, derived peptides from natural sources have gained a greater attention in the last two decades. Aquatic organisms including plants, fish and shellfish are known as a rich reservoir of parent protein molecules which can offer novel sequences of amino acids in peptides, having unique bio-functional properties upon hydrolyzing with proteases from different sources. However, rather than exploiting fish and shellfish stocks which are already under pressure due to overexploitation, the processing discards, regarded as secondary raw material, could be a potential choice for peptide based therapeutic development strategies. In this connection, we have attempted to review the scientific reports in this area of research that deal with some of the well-established bioactive properties, such as antihypertensive, anti-oxidative, anti-coagulative, antibacterial and anticarcinogenic properties, with reference to the type of enzymes, substrate used, degree of particular bio-functionality, mechanism, and wherever possible, the active amino acid sequences in peptides. Many of the studies have been conducted on hydrolysate (crude mixture of peptides) enriched with low molecular bioactive peptides. In vitro and in vivo experiments on the potency of bioactive peptides to modulate the human physiological functions beneficially have demonstrated that these peptides can be used in the prevention and treatment of non-communicable lifestyle mediated diseases. The information synthesized under this review could serve as a point of reference to drive further research on and development of functionally active therapeutic natural peptides. Availability of such scientific information is expected to open up new zones of investigation for adding value to underutilized secondary raw materials, which in turn paves the way for sustainability in fish processing. However, there are significant challenges ahead in exploring the fish waste as a source of bioactive peptides, as it demands more studies on mechanisms and structure-function relationship understanding as well as clearance from regulatory and statutory bodies before reaching the end user in the form of supplement or therapeutics.

Indexed as

FishesFish ProteinsFood-Processing IndustryPeptidesWaste ProductsAnimalsGelatinHumansHydrolysisFish ProteinsGelatinPeptidesWaste ProductsACE inhibitory activityantioxidantsbioactive peptidesfishery by-productfish proteins

Identifiers

PMID34564142
PMCPMC8468292
OpenAlexW3195197135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.